TABLE I.
Prader-Willi syndrome (N = 23) | Control subjects (N = 18) | |||
---|---|---|---|---|
Characteristic | [mean±SD (range)] | [mean ± SD (range)] | F-value | P-value |
Age | 8.2 ± 2.0 year (5–11 year) | 8.2 ± 2.3 year (5–11 year) | 0.07 | 0.79 |
BMI | 20.7 ± 5.0 (l4–28) | 18.2 ± 3.3 (15–25) | 2.2 | 0.15 |
BMI z-score | 0.96 ± 1.4 (13–32) | 0.52 ± 1.35 (12–26) | 1.1 | 0.31 |
Percent body fat | 33 ± 13% (13–54%) | 24 ± 10% (10–47%) | 5.5 | 0.02* |
Oxytocin levels [mean pg/ml ± SD (range, N)] | ||||
All subjects | 167 ± 121 (4.68–391, N = 23) | 64.8 ± 83.8 (4.68–247, N = 18) | 8.8 | 0.01* |
Female subjects (N = 18) | 155 ± 141 (4.68–391, N = 10) | 65.3 ± 84.4 (4.68–247, N = 8) | 1.4 | 0.26 |
Male subjects (N = 23) | 172 ± 109 (4.68–332, N = 13) | 64.3 ± 87.9 (4.68–245, N = 10) | 9.3 | 0.01* |
Indicated statistical significance.